Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Low Levels of β-Lactam Antibiotics Induce Extracellular DNA Release and Biofilm Formation in Staphylococcus aureus
2012
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Zygomycosis Due to Apophysomyces elegansReport of 2 Cases and Review of the Literature
1999
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Zygomycosis Due to Apophysomyces elegans
1999
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Mucormycosis (Zygomycosis) in a Heart-Kidney Transplant Recipient: Recovery after Posaconazole Therapy
2003
Inflammation and metabolic disorders
2006 StandoutNature
Synergy of ultrasound microbubbles and vancomycin against Staphylococcus epidermidis biofilm
2012
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Impact of obesity on treatment of chronic hepatitis C†
2006
General Principles of Antimicrobial Therapy
2011
Material properties of biofilms—a review of methods for understanding permeability and mechanics
2015
Deciphering mechanisms of staphylococcal biofilm evasion of host immunity
2012
Fungal Disease of the Nose and Sinuses: An Updated Overview
2012
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Aspergillusendocarditis 2003–2009
2010
The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
2008
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
2020
Pancreatic cancer
2016 Standout
Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects
2009 Standout
Intestinal microbiota and nonalcoholic steatohepatitis
2017
Taenia solium cysticercosis
2003 Standout
miR-122 is a Unique Molecule with Great Potential in Diagnosis, Prognosis of Liver Disease, and Therapy Both as miRNA Mimic and Antimir
2015
Obstructive Sleep Apnea, Insulin Resistance, and Steatohepatitis in Severe Obesity
2008
Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2015
Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: A meta-analysis
2014
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Biofilms: an emergent form of bacterial life
2016 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Non-alcoholic fatty liver disease
2021 Standout
Locally Invasive Cutaneous Apophysomyces elegans Infection Acquired From Snapdragon Patch Test
2002
Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease
2013
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
2009
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Rhino-orbitocerebral Mucormycosis Attributable to Apophysomyces elegans in an Immunocompetent Individual: Case Report and Review of the Literature
2001
Staphylococcus aureus biofilms: recent developments in biofilm dispersal
2014
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome
2009
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment
2004
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
2012
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
2009
Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants
2017
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease
2018
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?
2013
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
2008
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
2017
Parasites in fine needle breast aspirates—assessment of host tissue response
2002
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Zygomycetes in Human Disease
2000 Standout
Current treatment of non‐alcoholic fatty liver disease
2008
Prevalence of non-alcoholic fatty liver disease: population based study
2007
The extracellular matrix protects P seudomonas aeruginosa biofilms by limiting the penetration of tobramycin
2013
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
2017
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Histopathologic Diagnosis of Fungal Infections in the 21st Century
2011
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
The global burden of lung cancer: current status and future trends
2023
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Redox theory of aging: implications for health and disease
2017
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control
2015
Neuro‐ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature
2012
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
2013
Nonalcoholic Fatty Liver Disease
2015 Standout
Invasive disease due to Mucorales: a case report and review of the literature.
2001
Gut Microbiota and Host Reaction in Liver Diseases
2015
Inorganic nanoparticles engineered to attack bacteria
2015
Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges
2016
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of Ashim Das being referenced
Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions
2007
Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD)
2012
Fine‐needle aspiration cytology in the diagnosis of cysticercosis presenting as palpable nodules
1991
Primary Cutaneous Zygomycosis Due to Saksenaea vasiformis and Apophysomyces elegans
1997
Overexpression of microRNA‐122 enhances in vitro hepatic differentiation of fetal liver‐derived stem/progenitor cells
2013
Craniofacial zygomycosis caused by Apophysomyces elegans
1997
Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis
2012
Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease
2013
Spectrum of fungal rhinosinusitis; histopathologist’s perspective
2009
Aspergillus endocarditis in a known case of allergic bronchopulmonary aspergillosis: an autopsy report
2009
Ten Years' Experience in Zygomycosis at a Tertiary Care Centre in India
2001
Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center
2015
Controversies surrounding the categorization of fungal sinusitis
2008
The Clinicopathological Profile of Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD) is Different from That in the West
2007
Allergic Fungal Rhinosinusitis
2006
Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms
2010
Clinical Significance of Genotypes and Precore/Basal Core Promoter Mutations in HBV Related Chronic Liver Disease Patients in North India
2009
Role of 18F ‐fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: Experience from tropics
2012
Small intestinal bacterial overgrowth and toll‐like receptor signaling in patients with non‐alcoholic fatty liver disease
2015
Small Intestinal Bacterial Overgrowth and Toll-Like Receptor Signaling in Patients With Nonalcoholic Fatty Liver Disease: Presidential Poster
2015
Demonstration of insulin-specific mRNA in cultured rat retinal glial cells.
1987
Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis--a preliminary report.
2004
Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key
2017
Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis.
2004